The global human growth hormone market size was valued at USD 6.81 billion in 2024 and is projected to reach from USD 7.63 billion in 2025 to USD 18.75 billion by 2033, growing at a CAGR of 11.90% ...

New research highlights BCL6 protein’s role in preventing muscle loss during GLP-1 medication use, offering hope for ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.

A protein, BCL6, has been identified as a key molecule for maintaining healthy muscle mass while losing fat, suggesting that ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...

However, mounting scientific evidence suggests that consuming Red 3 poses significant health risks. These risks prompted California to ban its use in food in 2023 and the Food and Drug Administration ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...

Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

On January 17, 2025, the Food and Drug Administration (FDA) approved datopotamab deruxtecan-dlnk a Trop-2-directed antibody ...